Charlotte A. Bradbury

Bristol, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).

Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).

Journal: Critical care medicine

Published: May 08, 2026

Use of andexanet alfa: A British Society for Haematology position statement.

Use of andexanet alfa: A British Society for Haematology position statement.

Journal: British journal of haematology

Published: February 10, 2026

The incidence of early recurrent venous thromboembolism: a systematic review and meta-analysis.

The incidence of early recurrent venous thromboembolism: a systematic review and meta-analysis.

Journal: Research and practice in thrombosis and haemostasis

Published: October 01, 2025

Intermediate- versus prophylactic-dose heparin for hospitalised patients with COVID-19: an updated meta-analysis of randomised trials.

Intermediate- versus prophylactic-dose heparin for hospitalised patients with COVID-19: an updated meta-analysis of randomised trials.

Journal: Intensive care medicine

Published: July 31, 2025

Appropriate Management of Thrombotic Risk in Patients With Primary Immune Thrombocytopenia in the UK: A Modified Delphi Consensus.

Appropriate Management of Thrombotic Risk in Patients With Primary Immune Thrombocytopenia in the UK: A Modified Delphi Consensus.

Journal: EJHaem

Published: May 14, 2025

Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial.

Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial.

Journal: Research and practice in thrombosis and haemostasis

Published: January 28, 2025

Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial.

Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial.

Journal: Thorax

Published: September 19, 2024

Coproducing Health Information Materials With Young People: Reflections and Lessons Learned.

Coproducing Health Information Materials With Young People: Reflections and Lessons Learned.

Journal: Health expectations : an international journal of public participation in health care and health policy

Published: February 06, 2024

2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19.

2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 23, 2023

Simvastatin in Critically Ill Patients with Covid-19.

Simvastatin in Critically Ill Patients with Covid-19.

Journal: The New England journal of medicine

Published: October 27, 2023

Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.

Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.

Journal: JAMA

Published: October 25, 2023

Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19.

Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19.

Journal: JACC. Advances

Published: June 07, 2023

Showing 1-12 of 62

Last Updated: 09/26/2026